We are live on ! Find out more
SBH

Segall Bryant & Hamill Portfolio holdings

AUM $6.98B
1-Year Est. Return 34.78%
This Fund
S&P 500
This Quarter Est. Return
+4.24%
1 Year Est. Return
+34.78%
3 Year Est. Return
+85.12%
5 Year Est. Return
+106.02%
10 Year Est. Return
+446.97%
AUM
$4.31B
AUM Growth
+$60.9M
Cap. Flow
-$73.3M
Cap. Flow %
-1.7%
Top 10 Hldgs %
16.36%
Holding
590
New
34
Increased
175
Reduced
265
Closed
22

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$26.3M
2
OKE icon
Oneok
OKE
+$18.5M
3
BAX icon
Baxter International
BAX
+$17.2M
4
AVY icon
Avery Dennison
AVY
+$12.8M
5
ICUI icon
ICU Medical
ICUI
+$11.8M

Top Sells

Rank Stock Value
1
AYI icon
Acuity Brands
AYI
+$23.3M
2
PPG icon
PPG Industries
PPG
+$22.4M
3
EFX icon
Equifax
EFX
+$19M
4
OKS
Oneok Partners LP
OKS
+$17.7M
5
MDT icon
Medtronic
MDT
+$17.5M

Sector Composition

Rank Sector Weight
1 Healthcare 17.99%
2 Industrials 16.07%
3 Financials 14.59%
4 Technology 13.97%
5 Consumer Discretionary 9.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLX icon
426
Clorox
CLX
$11.6B
$511K 0.01%
3,875
-336
-8% -$45.1K
SYY icon
427
Sysco
SYY
$39.7B
$506K 0.01%
9,374
AXP icon
428
American Express
AXP
$223B
$505K 0.01%
5,578
+1,126
+25% +$96.8K
ENB icon
429
Enbridge
ENB
$124B
$498K 0.01%
11,905
+2,952
+33% +$120K
ETP
430
DELISTED
Energy Transfer Partners, L.P.
ETP
$493K 0.01%
26,971
TGT icon
431
Target
TGT
$62.1B
$482K 0.01%
8,171
+1,396
+21% +$78.2K
TWX
432
DELISTED
Time Warner Inc
TWX
$482K 0.01%
4,707
+1,065
+29% +$108K
KDP icon
433
Keurig Dr Pepper
KDP
$40.4B
$480K 0.01%
5,422
-250
-4% -$22.7K
ROST icon
434
Ross Stores
ROST
$76.6B
$478K 0.01%
7,400
CSW
435
CSW Industrials
CSW
$4.71B
$473K 0.01%
10,664
LMT icon
436
Lockheed Martin
LMT
$134B
$471K 0.01%
1,518
+518
+52% +$155K
NGL icon
437
NGL Energy Partners
NGL
$1.94B
$468K 0.01%
40,500
REGN icon
438
Regeneron Pharmaceuticals
REGN
$68.8B
$468K 0.01%
1,047
BMO icon
439
Bank of Montreal
BMO
$125B
$463K 0.01%
6,111
PII icon
440
Polaris
PII
$4.15B
$462K 0.01%
4,416
-616
-12% -$58.4K
PDCO
441
DELISTED
Patterson Companies, Inc.
PDCO
$458K 0.01%
11,850
MSCI icon
442
MSCI
MSCI
$40B
$447K 0.01%
3,825
-593
-13% -$65.8K
PX
443
DELISTED
Praxair Inc
PX
$447K 0.01%
3,200
OEF icon
444
iShares S&P 100 ETF
OEF
$19.8B
$432K 0.01%
3,879
BIVV
445
DELISTED
Bioverativ Inc. Common Stock
BIVV
$425K 0.01%
7,450
-300
-4% -$17.6K
LBTYA icon
446
Liberty Global Class A
LBTYA
$3.31B
$421K 0.01%
12,416
DIA icon
447
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$45.3B
$417K 0.01%
1,863
-125
-6% -$27.4K
MDLZ icon
448
Mondelez International
MDLZ
$77.7B
$416K 0.01%
10,228
+1,484
+17% +$63K
CB icon
449
Chubb
CB
$140B
$413K 0.01%
2,896
SEIC icon
450
SEI Investments
SEIC
$11.9B
$411K 0.01%
6,732

Similar funds

Segall Bryant & Hamill's Q3 2017 Portfolio in Review

As of Q3 2017, Segall Bryant & Hamill held 590 positions worth $4.31B, up 1.4% from $4.24B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Segall Bryant & Hamill's Q3 2017 filing shows 34 new, 175 increased, 265 reduced and 22 closed positions. Its largest new stake was ICU Medical: 67,735 shares worth $12.6M. The largest sale was Acuity Brands, an estimated $23.3M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 18% a quarter earlier, followed by Industrials and Financials.

  • Segall Bryant & Hamill's largest Q3 2017 buy was ICU Medical: 67,735 shares worth $12.6M.
  • Segall Bryant & Hamill added most to Thermo Fisher Scientific in Q3 2017, an estimated $26.3M increase.
  • Segall Bryant & Hamill's biggest Q3 2017 reduction was Acuity Brands, cutting an estimated $23.3M.
  • Segall Bryant & Hamill fully exited Oneok Partners LP in Q3 2017, selling an estimated $17.7M.
  • Segall Bryant & Hamill's ten largest holdings make up 16% of its $4.31B portfolio in Q3 2017.
  • Segall Bryant & Hamill opened 34 new positions and closed 22 in Q3 2017.
  • Segall Bryant & Hamill's portfolio value rose 1.4% quarter-over-quarter to $4.31B.

Based on Segall Bryant & Hamill's 13F filing for Q3 2017, filed 14 Nov 2017.